← Back to Search

Device

Novel Spectacle Lenses for Myopia (EUCALYPTUS Trial)

N/A

Recruiting

Research Sponsored by SightGlass Vision, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Children 6 - 8 years of age (inclusive) at time of informed consent/assent

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

EUCALYPTUS Trial Summary

This trial tests the long-term effectiveness of a treatment for younger children to predict 3-year outcomes; results from 12-month study will be used.

Who is the study for?

This trial is for children aged 6-8 with mild to moderate near-sightedness (myopia) who have good vision with glasses and no more than a small difference in prescription between their eyes. They must be able to wear the study glasses at least 10 hours a day, not use contact lenses, and have no eye conditions or systemic diseases affecting vision.Check my eligibility

What is being tested?

The study tests if special spectacle lenses can control worsening myopia in young children compared to regular single-vision lenses. It's a masked study where neither participants nor observers know which type of lens each child gets, randomly assigning kids into two groups equally.See study design

What are the potential side effects?

Since this trial involves wearing different types of spectacle lenses, there are minimal side effects expected. However, some discomfort or adjustment issues may occur when switching from previous eyewear to the test spectacles.

EUCALYPTUS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My child is between 6 and 8 years old.

EUCALYPTUS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Spherical equivalent refraction

Secondary outcome measures

Axial length

EUCALYPTUS Trial Design

2Treatment groups

Experimental Treatment

Group I: Test Arm 2Experimental Treatment1 Intervention

Single vision, impact-resistant spectacle lenses

Group II: Test Arm 1Experimental Treatment1 Intervention

Single vision, impact-resistant spectacle lenses

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

SightGlass Vision, Inc.Lead Sponsor

10 Previous Clinical Trials

943 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who can qualify for inclusion in this research project?

"This clinical study is looking to recruit 150 people that are between 6 and 8 years old with near-sightedness."

Answered by AI

Is participation in this medical research open to seniors above sixty years of age?

"To be eligible for this clinical trial, a participant must range from 6 to 8 in age. There are 83 trials intended for minors and 21 specifically designed for seniors above the age of 65."

Answered by AI

Is enrollment available for this experiment?

"Clinicaltrials.gov reveals that this clinical trial is not currently seeking volunteers, having been first posted on September 30th 2023 and last updated on the 5th of September in the same year. Even though this study has closed enrollment, there are still a total of 120 other medical trials actively recruiting patients at present."

Answered by AI

Are any US-based healthcare facilities currently administering this trial?

"Currently, the trial is operational at 4 medical centres such as Athens Eye Care in Athens, Procare Vision Centers, Inc. in Granville and Bellaire Family Eye Care located in Bellaire."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens

2023. "Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06034327.

All > Myopia